Beeline Medicines
The Associate Director, Regulatory Strategy at Beeline Medicines develops and implements regulatory strategies for therapeutics in Immunology & Inflammation, guiding products from IND/CTA through BLA/NDA/MAA submission. This role involves cross-functional collaboration with Clinical, Medical Affairs, and Program Leadership to ensure regulatory compliance and strategy alignment.
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies that target the drivers of immune dysfunction. The company is advancing a pipeline of therapies for autoimmune and inflammatory diseases, including its lead program afimetoran, a TLR7/8 inhibitor in late-stage clinical development for lupus. Beeline Medicines aims to define new treatment paradigms for patients living with chronic immune-mediated conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beeline Medicines.
4% above the average for this role
Sr. Manager, Regulatory Lead
Alfasigma
Director, Regulatory Affairs - US Filing Lead
Revolution Medicines
Director, Regulatory Affairs (US Filing Lead)
Revolution Medicines
Associate Director, AS&T Lifecycle Management (Biological Method Expert)
BioNTech
Senior Manager, Regulatory Affairs
Nuvalent, Inc.
Principal Medical Writer
Revolution Medicines